Corrigendum: Refractory human cytomegalovirus infection without evidence of genetic resistance in the UL-54 and UL-97 genes in a pediatric hematopoietic stem cell transplant recipient: a case report.

[This corrects the article DOI: 10.3389/fmed.2024.

Haploidentical Stem Cell Transplantation With TCR αβ/CD19 Depletion in Children With Nonmalignant Hematologic Disorders: Outcomes From a Referral Center in Peru.

Background: Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with TCR αβ/CD19 cell depletion is a promising therapeutic alternative for children with nonmalignant hematologic disorders, especially in low-income countries where finding a compatible donor is challenging. The use of this transplantation approach for nonmalignant hematologic disorders has not been previously described in the Peruvian pediatric population.

Methods: We present the outcomes of children under 19 with nonmalignant hematologic disorders who underwent haplo-HSCT with TCR αβ/CD19 cell depletion between 2018-2022 at a referral center in Lima, Peru.